Pourová Radka, Janousek Petr, Jurovcík Michal, Dvoráková Marcela, Malíková Marcela, Rasková Dagmar, Bendová Olga, Leonardi Emanuela, Murgia Alessandra, Kabelka Zdenek, Astl Jaromír, Seeman Pavel
Department of Paediatric Neurology, DNA Laboratory, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.
Ann Hum Genet. 2010 Jul;74(4):299-307. doi: 10.1111/j.1469-1809.2010.00581.x.
Mutations in SLC26A4 cause Pendred syndrome (PS) - hearing loss with goitre - or DFNB4 - non-syndromic hearing loss (NSHL) with inner ear abnormalities such as Enlarged Vestibular Aqueduct (EVA) or Mondini Dysplasia (MD). We tested 303 unrelated Czech patients with early hearing loss (298 with NSHL and 5 with PS), all GJB2-negative, for SLC26A4 mutations and evaluated their clinical and radiological phenotype. Among 115 available HRCT/MRI scans we detected three MD (2.6%), three Mondini-like affections (2.6%), 16 EVA (13 bilateral - 19.2% and 15.6% respectively) and 61 EVA/MD-negative scans (73.4%). We found mutation(s) in 26 patients (8.6%) and biallelic mutations in eight patients (2.7%) out of 303 tested. In 18 of 26 (69%) patients, no second mutation could be detected even using MLPA. The spectrum of SLC26A4 mutations in Czech patients is broad without any prevalent mutation. We detected 21 different mutations (four novel). The most frequent mutations were p.Val138Phe and p.Leu445Trp (18% and 8.9% of pathogenic alleles respectively). Among 13 patients with bilateral EVA, six patients (50%) carry biallelic mutations. In EVA -negative patients no biallelic mutations were found but 4.9% had monoallelic mutations. SLC26A4 mutations are present mostly in patients with EVA/MD and/or progressive HL and those with affected siblings.
SLC26A4基因突变可导致 Pendred 综合征(PS)——伴有甲状腺肿的听力损失,或 DFNB4——伴有内耳异常(如前庭导水管扩大(EVA)或 Mondini 发育不全(MD))的非综合征性听力损失(NSHL)。我们对 303 例非亲缘关系的早期听力损失捷克患者(298 例 NSHL 和 5 例 PS)进行了 SLC26A4 基因突变检测,所有患者GJB2基因均为阴性,并评估了他们的临床和放射学表型。在 115 份可用的高分辨率计算机断层扫描(HRCT)/磁共振成像(MRI)扫描中,我们检测到 3 例 MD(2.6%)、3 例 Mondini 样病变(2.6%)、16 例 EVA(13 例双侧病变——分别为 19.2%和 15.6%)以及 61 例 EVA/MD 阴性扫描(73.4%)。在 303 例检测患者中,我们发现 26 例(8.6%)有突变,8 例(2.7%)有双等位基因突变。在 26 例患者中的 18 例(69%)中,即使使用多重连接探针扩增技术(MLPA)也未检测到第二个突变。捷克患者中 SLC26A4 基因突变谱广泛,没有任何常见突变。我们检测到 21 种不同突变(4 种为新突变)。最常见的突变是 p.Val138Phe 和 p.Leu445Trp(分别占致病等位基因的 18%和 8.9%)。在 13 例双侧 EVA 患者中,6 例(50%)携带双等位基因突变。在 EVA 阴性患者中未发现双等位基因突变,但 4.9%有单等位基因突变。SLC26A4 基因突变主要存在于 EVA/MD 和/或进行性听力损失患者以及有患病同胞的患者中。